PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2026Journal of the Neurological Sciences0 citations

Polymerized type I collagen as a treatment for long COVID

View Full Paper
LCLuis Del Carpio-OrantesEl Colegio de VeracruzMPMiguel Arnulfo Perfecto-ArroyoInstituto Argentino de Diagnóstico y TratamientoNMNancy Moreno-Aldama

Key Points

  • Symptoms of long COVID improved significantly with polymerized type I collagen treatment, showing efficacy.
  • Marked improvement in fatigue and breathlessness was noted after treatment sessions.
  • Assessment through immune response markers indicated changes post-intervention with collagen.
  • These findings support the potential of polymerized type I collagen in managing long COVID symptoms.
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Carpio-Orantes et al. (2025) studied this question.

synapsesocial.com/papers/69a75f6cc6e9836116a2acb8https://doi.org/10.1016/j.jns.2025.125157
Ask AI
Helpful
Bookmark
Share
View Full Paper